Oncolytics Biotech is trading at $0.86 (-5.03%) today, moving lower in alignment with a weak tape for small-cap biotech names despite a lack of company-specific news.
- No specific catalysts were found to explain the price action, suggesting the move is driven by broader sector sentiment.
- The decline occurs as the Nasdaq trades lower and overall U.S. markets remain mixed.